Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Hormone and metabolic patterns in hypothalamus-like brain cells from people with anorexia nervosa

Official title: HOrmone Profiles and Energy Metabolism Signatures in Hypothalamic-like Neurons Generated From Patients With Anorexia Nervosa

Run by University of Zurich · NCT07580209 · Data updated 2026-11-12

This study will test whether hypothalamic-like neurons made from adult women with long-standing anorexia nervosa respond differently to metabolic hormones than neurons from healthy women.

More Anorexia Nervosa trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment10 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich)
StatusRecruiting
StartedApril 30, 2026
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedMay 12, 2026
Trial IDNCT07580209 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult premenopausal women aged 18–45 with severe and enduring anorexia nervosa (illness duration ≥7 years), current or recent BMI ≤18.5 kg/m², able to consent and proficient in German are ideal candidates.

Probably not a fit

People who are male, younger than 18 or older than 45, currently pregnant or breastfeeding, with severe medical comorbidities, substance dependence, current psychosis, or taking medications that strongly alter metabolic or endocrine function are unlikely to be eligible or benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect biological samples from premenopausal women with severe, enduring anorexia nervosa and from matched healthy female controls and derive hypothalamic-like neurons from those samples. They will expose these cells to key metabolic hormones and compare hormone responsiveness, cellular metabolism, gene expression profiles, and neuronal activity between groups. The work uses patient-derived cellular models and molecular and functional assays to identify neuroendocrine differences relevant to energy homeostasis. Results aim to link cell-level signatures to clinical features of anorexia nervosa and guide future hypothesis-driven therapeutic research.

Why it matters

Potential benefit: If successful, the work could identify biological mechanisms that point to new targets for treatments and help explain disturbances in energy regulation in anorexia nervosa.

How similar studies have gone: Patient-derived neuronal models for psychiatric and metabolic features are a relatively new approach; some prior work hints at altered neuronal signaling in eating disorders but mechanistic findings remain limited and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Female participants aged 18-45 years (premenopausal) Diagnosis of severe and enduring anorexia nervosa (illness duration ≥7 years, with documented functional impairment and non-response to appropriate treatments) Current BMI ≤18.5 kg/m² or documented BMI ≤18.5 kg/m² within the past 12 months Ability to provide informed consent Sufficient proficiency in the study language (German)

For healthy controls:

Female participants aged 18-45 years BMI between 18.5 and 24.9 kg/m² No current or past diagnosis of eating disorders No major psychiatric disorder Ability to provide informed consent

Exclusion Criteria:

Pregnancy or breastfeeding Severe medical comorbidities affecting metabolic or central nervous system function (e.g., uncontrolled endocrine, hepatic, renal, or cardiovascular diseases) Current psychosis or acute suicidality Current serious non-suicidal self-injury Substance dependence Use of medications that substantially alter metabolic or endocrine function (including high-dose systemic corticosteroids, hormonal contraceptives, or psychotropic medications such as antidepressants, antipsychotics, mood stabilizers, or anxiolytics) Positive status for HIV, hepatitis B (HBV), or hepatitis C (HCV) Intellectual disability impairing the ability to provide informed consent Insufficient proficiency in the study language

Where it's running

  • Private Praxis, Prof. Dr. Med. Gabriella Milos
    Zurich, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Maria Consolata Miletta, PhD — University of Zurich
  • Study coordinator: Maria Consolata Miletta, PhD
  • Email: maria.miletta@uzh.ch
  • Phone: +41(0)432533105

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.